Palogic Value Management’s Equifax EFX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$272K Buy
1,713
+197
+13% +$33.6K 0.09% 175
2026
Q1
$273K Sell
1,516
-32
-2% -$6.36K 0.12% 155
2025
Q4
$336K Buy
1,548
+321
+26% +$70.3K 0.14% 134
2025
Q3
$315K Hold
1,227
0.13% 135
2025
Q2
$318K Buy
1,227
+78
+7% +$19.8K 0.13% 130
2025
Q1
$280K Buy
1,149
+83
+8% +$20.9K 0.12% 129
2024
Q4
$272K Buy
1,066
+12
+1% +$3.21K 0.1% 140
2024
Q3
$310K Sell
1,054
-29
-3% -$8.18K 0.11% 143
2024
Q2
$263K Buy
1,083
+21
+2% +$5.01K 0.11% 136
2024
Q1
$284K Buy
1,062
+9
+0.9% +$2.29K 0.12% 130
2023
Q4
$260K Buy
+1,053
New +$214K 0.12% 133
2023
Q3
Sell
-923
Closed -$217K 157
2023
Q2
$217K Buy
+923
New +$194K 0.1% 137

Other funds holding EFX

Palogic Value Management's EFX Position: Q2 2026 in Review

Palogic Value Management increased its Equifax (EFX) stake by 13% in Q2 2026, buying an estimated $33.6K and bringing the position to 1,713 shares worth $272K. The position accounts for 0.09% of the portfolio, ranked #175.

Palogic Value Management first reported a position in EFX in Q2 2023 and has held it in 12 quarters since. The position peaked at $336K in Q4 2025. 835 funds tracked by Wall St. Rank hold EFX as of Q2 2026.

  • Palogic Value Management held 1,713 shares of Equifax worth $272K as of Q2 2026.
  • Palogic Value Management bought 197 Equifax shares in Q2 2026, an estimated $33.6K.
  • Equifax made up 0.09% of Palogic Value Management's portfolio in Q2 2026, its #175 holding.
  • Palogic Value Management first reported a position in Equifax in Q2 2023 and has held it in 12 quarters since.
  • Palogic Value Management's Equifax position peaked at $336K in Q4 2025.
  • 835 funds tracked by Wall St. Rank held Equifax as of Q2 2026.

Based on Palogic Value Management's 13F filing for Q2 2026, filed 14 Aug 2026.